Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

by Morschhauser, Franck , Daguindau, Nicolas , Tilly, Hervé , López-Guillermo, Armando , Sehn, Laurie H , Liu, David , Fowler, Nathan H , Martin Garcia-Sancho, Alejandro , Cartron, Guillaume , Le Gouill, Steven , Bartlett, Nancy L , Haioun, Corinne , Fruchart, Christophe , Tobinai, Kensei , Xerri, Luc , Palomba, M. Lia , Brice, Pauline , Libby, Edward N , Larouche, Jean-François , Flinn, Ian W , Ribrag, Vincent , Feugier, Pierre , Gomes da Silva, Maria , Maisonneuve, Hervé , Ysebaert, Loic , André, Marc , Wang, Jianming , Bouabdallah, Kamal , Bouabdallah, Reda , Zachée, Pierre , Salles, Gilles A , Pica, Gian M , Ando, Kiyoshi , Casasnovas, Rene-Olivier

in Adult / Advisors / Aged / Aged, 80 and over / Antineoplastic Combined Chemotherapy Protocols - adverse effects / Antineoplastic Combined Chemotherapy Protocols - therapeutic use / Apoptosis / Cancer / Chemotherapy / Clinical medicine / Disease-Free Survival / Fees & charges / Female / Humans / Immunomodulation / Immunotherapy / Intention to Treat Analysis / Lenalidomide / Life Sciences / Lymphocytes B / Lymphoma / Lymphoma, Follicular - drug therapy / Lymphoma, Follicular - mortality / Male / Middle Aged / Monoclonal antibodies / Neutropenia / Neutropenia - chemically induced / Patients / Rituximab / Rituximab - administration & dosage / Rituximab - adverse effects / Skin Diseases - chemically induced / Survival Rate / Targeted cancer therapy / Thalidomide - administration & dosage / Thalidomide - adverse effects / Thalidomide - analogs & derivatives

2018

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

2018

Confirm

Do you wish to request the book?

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

2018

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

Morschhauser, Franck,

Daguindau, Nicolas,

Tilly, Hervé,

López-Guillermo, Armando,

Sehn, Laurie H,

Liu, David,

Fowler, Nathan H,

Martin Garcia-Sancho, Alejandro,

Cartron, Guillaume,

Le Gouill, Steven,

Bartlett, Nancy L,

Haioun, Corinne,

Fruchart, Christophe,

Tobinai, Kensei,

Xerri, Luc,

Palomba, M. Lia,

Brice, Pauline,

Libby, Edward N,

Larouche, Jean-François,

Flinn, Ian W,

Ribrag, Vincent,

Feugier, Pierre,

Gomes da Silva, Maria,

Maisonneuve, Hervé,

Ysebaert, Loic,

André, Marc,

Wang, Jianming,

Bouabdallah, Kamal,

Bouabdallah, Reda,

Zachée, Pierre,

Salles, Gilles A,

Pica, Gian M,

Ando, Kiyoshi,

Casasnovas, Rene-Olivier

2018

Overview

The combination of rituximab and lenalidomide achieved results that were similar to those of rituximab plus chemotherapy in the treatment of previously untreated patients with advanced follicular lymphoma.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Adult

/ Advisors

/ Aged

/ Aged, 80 and over

/ Antineoplastic Combined Chemotherapy Protocols - adverse effects

/ Antineoplastic Combined Chemotherapy Protocols - therapeutic use

/ Apoptosis